SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Supriya Lifescience informs about earnings call

05 Aug 2024 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Supriya Lifescience has informed that an earnings call will be held on Monday, August 12, 2024 at 11.00 am IST to discuss operational and financial performance of the Company for the quarter ended June 30, 2024 (Q1 of FY 2024-25). The invite giving requisite details including the pre-registration link and dial-in details is attached. This intimation is also being made available on the website of the Company at: https://supriyalifescience.com/ir-financial.php.

The above information is a part of company’s filings submitted to BSE.

Supriya Lifescience Share Price

645.50 8.60 (1.35%)
15-Apr-2026 10:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.40
Dr. Reddys Lab 1213.60
Cipla 1225.95
Zydus Lifesciences 930.95
Lupin 2336.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×